Wells Fargo & Company »

Fibrobiologics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Fibrobiologics shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Fibrobiologics

Tip: Access up to 7 years of quarterly data

All positions including Fibrobiologics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrobiologics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2026-03-31 $13 10 1.30

More positions owned by Wells Fargo & Company

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
NVIDIA Corporation Put Option (NVDA)
Ishares Tr Core S&p Ttl Stk (ITOT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon Put Option (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Core Msci Emkt (IEMG)

View all positions for Wells Fargo & Company

Top funds holding Fibrobiologics

Vanguard Capital Management
Fund Evaluation Group
Geode Capital Management
BlackRock
Cascade Financial Partners
Vanguard Fiduciary Trust
UBS Group
Goss Wealth Management
Vanguard Global Advisers
Royal Bank of Canada
Islay Capital Management
Bnp Paribas Arbitrage, Snc
Wells Fargo & Company

View all funds holding Fibrobiologics